Keywords: Ipsen, Menarini, Adenuric, Gout, Licensing, Teijin

Ipsen grants Menarini exclusive European rights to Adenuric in up to 132 million-euro deal

Article | 20 October 2009

Print This

French specialty drugs firm Ipsen has entered into an agreement granting Italy’s Menarini Group the exclusive licence rights to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in